Dose-ranging, randomized, clinical trial of atazanavir with lamivudine and stavudine in antiretroviral-naive subjects: 48-week resultsMURPHY, Robert L; SANNE, Ian; CAHN, Pedro et al.AIDS (London). 2003, Vol 17, Num 18, pp 2603-2614, issn 0269-9370, 12 p.Article

A multicenter, randomized, double-blind, placebo-controlled trial of recombinant human interleukin-10 in HIV-infected subjectsANGEL, Jonathan B; JACOBSON, Mark A; SKOLNIK, Paul R et al.AIDS (London). 2000, Vol 14, Num 16, pp 2503-2508, issn 0269-9370Article

The effects of the Roche AMPLICOR HIV-1 MONITOR® UltraSensitive Test versions 1.0 and 1.5 viral load assays and plasma collection tube type on determination of response to antiretroviral therapy and the inappropriateness of cross-study comparisonsGIORDANO, Michael; KELLEHER, Thomas; COLONNO, Richard J et al.Journal of clinical virology. 2006, Vol 35, Num 4, pp 420-425, issn 1386-6532, 6 p.Article

Comparison of once-daily atazanavir with efavirenz, each in combination with fixed-dose zidovudine and lamivudine, as initial therapy for patients infected with HIVSQUIRES, Kathleen; LAZZARIN, Adriano; SENSION, Michael et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 36, Num 5, pp 1011-1019, issn 1525-4135, 9 p.Article

Evaluation of Individual Fiber Wear Resistance Using Accelerated Life TestingGIORDANO, Michael A; SCHMID, Steven R.Tribology & lubrication technology. 2012, Vol 68, Num 2, issn 1545-858X, 44-53 [9 p.]Article

Effect of a four-week course of interleukin-10 on cytokine production in a placebo-controlled study of HIV-1-infected subjectsPOTT, Gregory B; SAILER, Carrie A; GRINT, Paul C et al.European cytokine network (Montrouge). 2007, Vol 18, Num 2, pp 49-58, issn 1148-5493, 10 p.Article

High dose oral ganciclovir treatment for cytomegalovirus retinitisLALEZARI, Jacob P; FRIEDBERG, Dorothy N; JUNG, Donald T et al.Journal of clinical virology. 2002, Vol 24, Num 1-2, pp 67-77, issn 1386-6532Article